02795cam a2200265 a 4500003000900000005001700009008004100026040002800067041000800095100003500103245028100138246022400419260005400643300005800697502014500755520136100900530002202261653004002283653002402323653001802347700004202365700004702407700004202454856003302496EG-GiCUC20250223031912.0180109s2017    ua dho f m    000 0 eng d  aEG-GiCUCbengcEG-GiCUC0 aeng0 aShimaa Abdelalim Mahmmoud Essa10aEfficacy of combined use of low intensity laser therapy and ultraviolet radiation in the treatment of relapsing-remitting  multiple sclerosis patients / cShimaa Abdelalim Mahmmoud Essa ; Supervised Yousry Mahmoud Mostafa , Shereen Mohamed Fathi Sheir , Ayatullah Farouk Ahmed15aفعالية الإستخدام المشترك لليزر منخفض الشدة والأشعة فوق البنفسجية فى علاج مرضى التصلب المتعدد الإنتكاسى- الإنحصاري   aCairo : bShimaa Abdelalim Mahmmoud Essa , c2017  a141 P. : bcharts , facsimiles , photographs ; c25cm  aThesis (Ph.D.) - Cairo University - National Institute of Laser Enhanced Sciences - Department of Laser Applications in Medicine and Biology  aBackground: Multiple sclerosis is an Inflammatory and neurodegenerative disease of the central nervous system of unknown reason or definite cure. Purpose: Proposing safe alternative therapies for the early management of multiple sclerosis. Study Design: Repeated measures randomized control trial. Materials and methods: 24 patients with relapsing-remitting multiple Sclerosis, from both sexes completed the study, age 25-45 years; randomly assigned into four groups. Seven patients in the control group (1); received monthly IV infusion of (1g) Solu-Medrol therapy for multiple sclerosis. Six Patients in group (2) received Solu-Medrol plus low intensity laser therapy LILT 850 nm. Six patients in group (3) received Solu-Medrol plus broad band ultraviolet B radiation BB-UVBR (280-320 nm). Five patients in group (4) received Solu-Medrol, scanner LILT and BB-UVBR; all three groups received sessions 3 days/week for 12 sessions. Expanded disability status Scale (EDSS), Fatigue severity scale (FSS), visual evoked potential (VEP), H-reflex latency, and H/M Ratio were assessed pre-treatment, post treatment, 3 months follow up. Results: Statistically significant reduction of fatigue severity FSS was recorded between the four groups post treatment (p=.013) in favor of group (4) and highly significant one (p=.005) at follow up in favor of the group (3)  aIssued also as CD 4aBroad Band Ultraviolet B Radiation  4aMultiple Sclerosis  4aPhototherapy 0 aAyatullah Farouk Ahmed , eSupervisor0 aShereen Mohamed Fathi Sheir , eSupervisor0 aYousry Mahmoud Mostafa , eSupervisor  uhttp://172.23.153.220/th.pdf